Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellin Berman

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Cancer|September 5, 2002
Financial analysis of patients with newly diagnosed acute myelogenous leukemia on protocol or standard therapyEllin Berman, Claudia Little, Bonnie Teschendorf, et al.
Leukemia Research|December 23, 2015
Stem cell transplantation in adults with acute myelogenous leukemia, normal cytogenetics, and the FLT3-ITD mutationEllin Berman, Molly Maloy, Sean Devlin, et al.
Leukemia Research|December 8, 2009
Elevations of creatine kinase in patients treated with imatinib mesylate (Gleevec)Jessica K Gordon, Steven K Magid, Robert G Maki, et al.
Leukemia Research|January 10, 2018
Disease characteristics and clinical outcomes in patients aged less than 40 with chronic lymphocytic leukemiaBartlomiej M Getta, Sean Devlin, Jae H Park, et al.
European Journal of Haematology|December 18, 2012
Rash with the multitargeted kinase inhibitors nilotinib and dasatinib: meta-analysis and clinical characterizationAaron M Drucker, Shenhong Wu, Klaus J Busam, et al.
The American Journal of Dermatopathology|September 8, 2025
Histopathologic and Clinical Characteristics of Cutaneous Toxicities of Tyrosine Kinase Inhibitors: Insights Into Pathologic Mechanisms From a Retrospective CohortIan Nykaza, Tania Platero-Portillo, Ellin Berman, et al.
Leukemia Research|September 23, 2016
Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS)Ellin Berman, Suresh Jhanwar, Cyrus Hedvat, et al.
Leukemia Research|March 12, 2013
Effect of long term imatinib on bone in adults with chronic myelogenous leukemia and gastrointestinal stromal tumorsEllin Berman, Monica Girotra, Catherine Cheng, et al.
The New England Journal of Medicine|May 12, 2006
Altered bone and mineral metabolism in patients receiving imatinib mesylateEllin Berman, Maria Nicolaides, Robert G Maki, et al.
The Journal of Infection|May 11, 2018
Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: A randomized studyDavid J Epstein, Susan K Seo, Yao-Ting Huang, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Cancer|September 5, 2002
Financial analysis of patients with newly diagnosed acute myelogenous leukemia on protocol or standard therapyEllin Berman, Claudia Little, Bonnie Teschendorf, et al.
Leukemia Research|December 23, 2015
Stem cell transplantation in adults with acute myelogenous leukemia, normal cytogenetics, and the FLT3-ITD mutationEllin Berman, Molly Maloy, Sean Devlin, et al.
Leukemia Research|December 8, 2009
Elevations of creatine kinase in patients treated with imatinib mesylate (Gleevec)Jessica K Gordon, Steven K Magid, Robert G Maki, et al.
Leukemia Research|January 10, 2018
Disease characteristics and clinical outcomes in patients aged less than 40 with chronic lymphocytic leukemiaBartlomiej M Getta, Sean Devlin, Jae H Park, et al.
European Journal of Haematology|December 18, 2012
Rash with the multitargeted kinase inhibitors nilotinib and dasatinib: meta-analysis and clinical characterizationAaron M Drucker, Shenhong Wu, Klaus J Busam, et al.
The American Journal of Dermatopathology|September 8, 2025
Histopathologic and Clinical Characteristics of Cutaneous Toxicities of Tyrosine Kinase Inhibitors: Insights Into Pathologic Mechanisms From a Retrospective CohortIan Nykaza, Tania Platero-Portillo, Ellin Berman, et al.
Leukemia Research|September 23, 2016
Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS)Ellin Berman, Suresh Jhanwar, Cyrus Hedvat, et al.
Leukemia Research|March 12, 2013
Effect of long term imatinib on bone in adults with chronic myelogenous leukemia and gastrointestinal stromal tumorsEllin Berman, Monica Girotra, Catherine Cheng, et al.
The New England Journal of Medicine|May 12, 2006
Altered bone and mineral metabolism in patients receiving imatinib mesylateEllin Berman, Maria Nicolaides, Robert G Maki, et al.
The Journal of Infection|May 11, 2018
Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: A randomized studyDavid J Epstein, Susan K Seo, Yao-Ting Huang, et al.
Pageof 5